GlassScriptPhysician profile
Mary E Holliday
NPI 1780775239
$4,138.56
in general payments reported to CMS, 2019-2025
35 companies · $968 in 2025
The $968 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $644 · 2022: $1,037 · 2023: $809 · 2024: $680 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,457.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $404.64 | 2022-2025 | Omnipod |
| Lilly USA, LLC | $359.12 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $346.09 | 2021-2025 | Freestyle Libre 3, Freestyle Libre, Eterna |
| Esperion Therapeutics, INC. | $320.47 | 2021-2024 | Nexletol |
| Abbvie INC. | $299.15 | 2021-2025 | |
| Tandem Diabetes Care, INC. | $275.35 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $274.87 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $267.63 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.66 | 2021-2025 | Jardiance |
| Dexcom, INC. | $178.07 | 2023-2025 | Dexcom G6 Transmitter |
| Vanda Pharmaceuticals INC. | $135.67 | 2021-2023 | Hetlioz |
| Sanofi-Aventis U.S. LLC | $134.28 | 2024-2025 | |
| Medtronic, INC. | $132.96 | 2022-2025 | Minimed 780g |
| Janssen Pharmaceuticals, INC | $101.62 | 2021-2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $63.57 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $60.58 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.29 | 2021-2025 | Xifaxan |
| Cequr Corporation | $50.75 | 2022-2024 | Cequr Simplicity |
| Glaxosmithkline, LLC. | $49.55 | 2021-2023 | Arexvy, Shingrix |
| Amneal Pharmaceuticals LLC | $45.05 | 2024 | Unithroid |
| Intuity Medical INC | $41.49 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Alexion Pharmaceuticals, INC. | $40.26 | 2022-2023 | Strensiq |
| Abiomed | $40.05 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.69 | 2022 | |
| Amgen INC. | $32.59 | 2024 | Krystexxa |
| Nevro Corp. | $29.57 | 2022 | |
| Axsome Therapeutics, INC. | $28.01 | 2024 | Auvelity |
| Sumitomo Pharma America, INC. | $25.22 | 2023 | Gemtesa |
| Ibsa Pharma INC. | $20.05 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.31 | 2022 | |
| Phadia US INC. | $18.86 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.89 | 2024 | Farxiga |
| Biohaven Pharmaceuticals, INC. | $15.36 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.88 | 2022 | |
| Pfizer INC. | $12.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Holliday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.